Medigene AG (LON: 0QGJ)

Medigene AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14.02	8.67	22.22	22.42	30.03	34.68
Short-Term Investments	-	8	11	-	-	20
Cash & Short-Term Investments	14.02	16.67	33.22	22.42	30.03	54.68
Cash Growth	-42.88%	-49.81%	48.21%	-25.36%	-45.08%	6.37%
Accounts Receivable	0.5	0.42	3.24	1.04	0.87	0.47
Other Receivables	-	0.62	0.13	0.29	1.09	1.56
Receivables	0.5	1.04	3.37	1.33	1.96	2.03
Prepaid Expenses	-	0.35	0.64	0.4	0.42	0.49
Other Current Assets	1.11	0.08	0.02	0.02	0.29	0.53
Total Current Assets	15.63	18.14	37.25	24.16	32.7	57.73
Property, Plant & Equipment	3.06	3.44	4.39	4.9	6.88	8.82
Long-Term Investments	-	-	-	-	3.25	3.44
Goodwill	-	-	-	-	-	2.21
Other Intangible Assets	9.84	9.85	9.75	30.12	31.63	33.49
Other Long-Term Assets	0.29	0.29	0.29	0.29	0.29	3.52
Total Assets	28.81	31.72	51.68	59.47	74.75	109.22
Accounts Payable	0.41	0.34	0.63	0.5	0.43	1.37
Accrued Expenses	-	0.71	0.74	1.81	1.17	-
Current Portion of Leases	0.94	0.91	0.98	0.89	1.16	1.07
Current Income Taxes Payable	-	0.41	1.19	-	-	-
Current Unearned Revenue	1.28	3.2	1.71	3.39	5.28	4.91
Other Current Liabilities	3.91	1.61	2.16	1.46	2.08	2.87
Total Current Liabilities	6.53	7.18	7.42	8.03	10.13	10.22
Long-Term Leases	1.61	2.04	2.75	3.14	3.99	4.93
Long-Term Unearned Revenue	-	0.43	3.62	0.37	3.76	9.04
Long-Term Deferred Tax Liabilities	0.64	0.64	0.29	2.52	2.8	2.44
Other Long-Term Liabilities	0.37	0.28	0.5	0.5	0.47	0.34
Total Liabilities	9.15	10.65	14.65	14.65	21.6	27.39
Common Stock	29.48	24.56	24.56	24.56	24.56	24.56
Retained Earnings	-492.92	-486.19	-470.01	-461.68	-451.7	-422.83
Comprehensive Income & Other	483.1	482.69	482.48	481.94	480.29	480.09
Shareholders' Equity	19.66	21.07	37.03	44.82	53.15	81.82
Total Liabilities & Equity	28.81	31.72	51.68	59.47	74.75	109.22
Total Debt	2.55	2.95	3.73	4.02	5.15	6
Net Cash (Debt)	11.48	13.72	29.5	18.39	24.88	48.68
Net Cash Growth	-45.51%	-53.47%	60.38%	-26.07%	-48.89%	-2.44%
Net Cash Per Share	0.91	1.12	2.40	1.50	2.03	3.96
Filing Date Shares Outstanding	14.74	12.28	12.28	12.28	12.28	12.28
Total Common Shares Outstanding	14.74	12.28	12.28	12.28	12.28	12.28
Working Capital	9.1	10.96	29.84	16.13	22.56	47.51
Book Value Per Share	1.33	1.72	3.01	3.65	4.33	6.66
Tangible Book Value	9.83	11.21	27.28	14.7	21.52	46.12
Tangible Book Value Per Share	0.67	0.91	2.22	1.20	1.75	3.76

Source: S&P Capital IQ. Standard template. Financial Sources.